AgeMate's Daily Longevity Blend and IM8's Daily Ultimate Essentials are two very different products that often sit on the same shortlist, which is where confusion starts. AgeMate is a 3.325 g morning scoop built around 500 mg of NMN; in Australia it is a listed medicine, with the number AUST L 529272 printed on the tub. IM8 is a 12 g all-in-one powder marketed with 90 ingredients across nine body systems, priced in US dollars, with no local Australian storefront. The two are not alternates for each other; they sit in different regulatory lanes and chase different jobs.
Readers landing on this comparison are usually weighing a monthly charge against two polished product pages, trying to work out which numbers are facts and which are framing. Page one of Google is largely review blogs and brand pages; almost none of them line the two up on their own labels.
This page does that, pulled from AgeMate's product page and IM8's product and ingredients pages on 28 October 2026: what each one is, what the serve delivers, what you pay, what each leaves out, and the regulatory split behind most differences.
What is AgeMate, and what is IM8?
AgeMate's Daily Longevity Blend is a berry-flavoured powder you stir into cold water each morning (one level scoop into 240 ml). One scoop weighs 3.325 g and is built around 500 mg of NMN (nicotinamide mononucleotide), with 14 further active ingredients at smaller amounts. It is manufactured in Sydney by LIPA, a TGA-licensed facility, and entered on Australia's Register of Therapeutic Goods under AUST L 529272. Its label limits everyday use to a 12-week stretch, extended only when a healthcare professional says so. Our full label read of the product sits in the AgeMate review.
IM8 Daily Ultimate Essentials is a one-scoop drink mix co-founded by David Beckham, with an advisory group drawn from US universities and research centres. One serving is 12 grams, mixed with 8 to 12 ounces of cold water, juice or smoothie, and the product page lists 90 ingredients across nine body systems. It carries NSF Certified for Sport certification and the brand states each batch is tested against 280-plus banned substances. The powder is manufactured in New Jersey by Vitaquest. Our full product-level read sits in the IM8 review (Australia).
Both pages present their drink as a one-step daily routine. One is a listed medicine with a tight set of actives at measurable doses; the other is a US-manufactured supplement with a broader ingredient list and no consolidated Australian nutrition panel on the public page.
AgeMate vs IM8 side by side
Everything in this table was read on 28 October 2026 from the brands' own product and ingredients pages. Where IM8 publishes an amount in US dollars, that is how it appears on the page; the brand's checkout can be switched to Australian dollars through its country selector.
| On the label and offer | AgeMate Daily Longevity Blend | IM8 Daily Ultimate Essentials |
|---|---|---|
| Regulatory category (Australia) | Listed medicine, AUST L 529272 | Supplement (not an Australian listed medicine) |
| Serving size | 3.325 g (level scoop) | 12 g (scoop or single-serve sachet) |
| Servings per container | 30 | Tub or single-serve sachets |
| Flagship ingredient | NMN 500 mg | 90 ingredients across nine body systems |
| Active ingredients disclosed | 15 actives at per-serve amounts | 90 named ingredients with per-serve amounts |
| Protein per serve | Not stated | Not stated |
| Dietary fibre per serve | Not stated | Not stated |
| Calories per serve | Described as "zero calorie" | Not stated |
| Probiotic or postbiotic | Not stated | 10 billion CFU + prebiotics + digestive enzymes |
| Added sugar | None stated | "No added sugar" |
| Caffeine | None stated | "No caffeine" |
| Flavours | Natural berry | Acai + Mixed Berries; Lemon + Orange; Mango + Passion Fruit |
| Third-party certification | TGA listed-medicine pathway; TGA-licensed facility (LIPA, Sydney) | NSF Certified for Sport; tested against 280-plus banned substances |
| Allergen flags on the label | Soy; phenylalanine; sulfites noted on page | Soy noted on page |
| Price per serve (lowest) | $2.48 AUD (Double Subscription, 60 serves at $149) | $2.61 USD (90-Day Supply at $235 billed every 12 weeks) |
| Price per serve (monthly) | $2.63 AUD (Single Subscription, 30 serves at $79) | $2.97 USD (30-Day Supply at $89 billed every 4 weeks) |
| One-time purchase | $99 AUD (Try Once; $3.30 by dividing $99 by 30 serves) | $112 USD (One Time Purchase) |
| Returns | 30 days, unopened items | 30 days monthly; 90 days quarterly subscription |
| Delivery note | Ships from Sydney | Free shipping UK, US, CA, EU; AU orders outside that tier |
Every figure above is from each brand's own pages on 28 October 2026; the AUST L number is listed by AgeMate on its Our Standards page. No row has been estimated to fill a gap.
Can you buy IM8 in Australia?
Yes, IM8 ships to Australia and its site accepts Australian dollars at checkout through the Country/region picker in the footer. There is no dedicated Australian storefront URL and the paths im8health.com/en-au/products/daily-ultimate-essentials and im8health.com/au/products/daily-ultimate-essentials both returned HTTP 404 on 28 October 2026. The public product page shows US-dollar pricing by default, and the brand's "Free Shipping" line lists UK, US, Canada and European Union only, so Australian orders fall outside that tier.
Practical consequence: an Australian subscriber is paying a US-dollar price that moves with the AUD/USD exchange rate, and shipping into Australia is a separate line on the invoice. AgeMate ships from Sydney, prices in Australian dollars and shows a single all-in price per serve. The closest related category read is IM8 vs AG1 (Australia).
Is AgeMate worth the money?
The question that pays for is comparability. AgeMate's cheapest serve on 28 October 2026 was $2.48 AUD, inside its 60-serve subscription at $149; the monthly subscription was $2.63 AUD and the one-time purchase worked out at $3.30 AUD by dividing $99 by 30 servings. The prices are all in a single currency.
The published human trials of NMN that we were able to retrieve test NMN on its own, not inside AgeMate's blend. A 60-day trial compared placebo against daily doses of 300 mg, 600 mg and 900 mg of the compound; blood NAD rose in every active arm, and the six-minute walk test lengthened across all three (Yi et al, GeroScience, 2023). A 12-week trial of 250 mg a day in men aged 65 and over reported "nominally significant" changes in gait speed and one grip test, with 42 men randomised and only 20 completing after a supplier mix-up at week six, no correction for multiple comparisons, and funding and NMN supplied by a corporate sponsor (journal npj Aging, 2022;8:5; Igarashi et al, PubMed). A 2025 pooled analysis of three to five trials per outcome in older adults found no measurable effect of NMN on SMI (skeletal muscle index), grip strength or walking pace (Prokopidis et al, Journal of Cachexia, Sarcopenia and Muscle, 2025). A 2026 safety meta-analysis of 15 trials at 250 to 2,000 mg a day over 14 days to 24 weeks found no excess adverse events and no measurable effect on body weight, blood sugar, HbA1c, lipids or systolic blood pressure (Yang et al, Nutrients, 2026).
AgeMate's 500 mg dose sits between the single-trial dose arms and has not been directly tested in a published trial we could find. Longevity supplements sets eight compound-level evidence summaries alongside each other.
Is IM8 actually effective?
IM8's product page cites a 12-week randomised controlled trial it commissioned, reporting that 95 per cent of users felt a boost. The methods and journal location are not stated in the readable text we retrieved on 28 October 2026, so we treat it as a brand claim rather than independent evidence.
What the ingredients page does hold is a per-serve amount against each of the 90 ingredients, letting a reader check the dose of a specific nutrient against intakes they already know. Published amounts include vitamin C 900 mg, vitamin B12 200 mcg as methylcobalamin, vitamin D3 50 mcg, magnesium 100 mg as bisglycinate, zinc 15 mg, calcium 160 mg, selenium 70 mcg, iodine 150 mcg, CoQ10 100 mg, MSM 1,500 mg, saffron 30 mg and probiotics 10 billion CFU from Bacillus coagulans BC99 and Bacillus subtilis DE111. For a reader working from a blood test, that transparency is useful.
Whether the mix moves a measurable outcome in your body depends on which inputs you lack, on the Standard 1.2.8 label reference used to express daily values, and on how your doctor reads your results. Do multivitamins work sets out the trial evidence on broad daily blends, and vitamin B12 deficiency sets out why a blood test outperforms any scoop for one specific nutrient.
What is the regulatory difference between them?
AgeMate is a listed medicine, carried on the Australian Register of Therapeutic Goods under the number AUST L 529272 as shown on its Our Standards page. The Therapeutic Goods Administration describes listed medicines plainly: lower-risk products containing pre-approved low-risk ingredients and making limited claims, "not individually assessed by us before supply", with the sponsor self-certifying compliance with safety, quality and efficacy requirements (TGA, listed medicines, read from an Internet Archive copy dated 21 September 2026).
IM8 does not carry an AUST L or AUST R number; its Australian status is that of an imported supplement sent from a US fulfilment chain. Its quality page describes its standards as NSF Certified for Sport and testing against 280-plus banned substances, which are third-party sport-anti-doping certifications rather than Australian medicine listings. The practical consequence for an Australian buyer is a different label of trust: AgeMate's AUST L number sits inside the national therapeutic-goods regime; IM8's NSF certification sits inside a sport-focused private assurance system.
Standard 1.2.7-8(b) of the Food Standards Code prevents a food from being compared with a good represented to be for therapeutic use; the two products on this page are read on their own labels, with no third-category product weighed into the verdict. This article is general information and not medical advice; a GP or pharmacist is the right call for anyone on regular medications or managing a condition.
Who is each one for?
Going only by the labels and the public offers:
- AgeMate suits a reader who wants a disclosed 500 mg of NMN in a small morning drink, an all-in Australian-dollar price, and the AUST L number on the tub as part of what they pay for. The one-time $99 AUD option and 30-day return on unopened items means a two-month trial costs about $198 AUD before any subscription. Children, pregnant and breastfeeding people, and anyone with a soy allergy or sulfite sensitivity are told plainly to avoid or check first.
- IM8 suits a reader who wants the longest disclosed ingredient list in a 12 g scoop, is comfortable paying in US dollars with international shipping, and weights NSF Certified for Sport status over an Australian listing number. The 90-day money-back window on the quarterly subscription makes a three-month try realistic. Protein and dietary fibre are not disclosed on the product page.
Neither product publishes a protein number, dietary-fibre number or energy figure on the headline panel. If your real question is "where does my daily protein come from", the answer is on neither label.
HLTH+ in context: a Formulated Supplementary Food category
HLTH+ sits in a different regulatory lane: a Formulated Supplementary Food under FSANZ Standard 2.9.3, built to supplement a normal diet rather than to make listed-medicine indications. One sachet declares 30g protein, 7g dietary fibre and 30 essential daily nutrients, at RRP $6.00. It carries no AUST L number, and this comparison does not weigh it against AgeMate or IM8. The HLTH+ life-stage products — Women's, Women's 50+, Men's and Men's 50+ — share one reference: they are formulated to the Nutrient Reference Values set by the National Health and Medical Research Council, the Australian Government Department of Health and Ageing and the New Zealand Ministry of Health. Running the ✦ Find My Formula quiz shows what your current routine is not giving you.
Frequently Asked Questions
Is AgeMate the same category as IM8 in Australia?
No. AgeMate is a listed medicine on the Australian Register of Therapeutic Goods under AUST L 529272, as shown on its Our Standards page. IM8 is an imported supplement delivered from a US fulfilment chain and does not carry an AUST L or AUST R number. The TGA pathway and brand-published certifications are different kinds of assurance.
Which costs less per serving?
On 28 October 2026 AgeMate's cheapest serve was $2.48 AUD on its 60-serve subscription and $2.63 AUD on its monthly plan. IM8's cheapest serve was $2.61 USD on its 90-day subscription; its monthly was $2.97 USD, and the one-time purchase worked out at $3.73 USD. Final AUD depends on checkout exchange.
How much NMN is in IM8 compared with AgeMate?
AgeMate's label declares 500 mg of NMN per 3.325 g scoop of Daily Longevity Blend. NMN is not listed in the per-serve panel of IM8's Daily Ultimate Essentials on their ingredients page retrieved on 28 October 2026; IM8 markets a separate product, Daily Ultimate Longevity, for NMN-focused use, which was out of scope here.
Do either product list protein and dietary fibre?
No. Neither AgeMate's Daily Longevity Blend nor IM8's Daily Ultimate Essentials publishes a protein number or a dietary-fibre number on the per-serve panel we retrieved on 28 October 2026. Both are small micronutrient-focused scoops rather than meal-sized formulas, which is why "daily nutrition" needs more than one line on a label.
Which is easier to buy in Australia?
AgeMate ships from Sydney, prices in Australian dollars and shows a single Australian return policy on its product page. IM8 ships internationally and its Country/region picker switches the storefront to AUD, but it has no dedicated Australian URL and its free-shipping tier lists the UK, US, Canada and European Union only, so Australian orders fall outside that tier.





Leave a comment
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.